Answers are grounded in this paper and cite their sources.
Introduction Brachial plexus injuries carry significant long‐term morbidity, and intraoperative differentiation of injury severity remains challenging, particularly in lesions in continuity and proximal/root‐level injuries. Multimodal intraoperative neuromonitoring (IONM) offers real‐time physiologic guidance during surgical decision‐making. However, it remains unclear how each modality should be applied and interpreted, what quantitative criteria define a positive nerve action potential (NAP), what IONM can establish about nerve injury grade, and how robust the supporting evidence is. This review synthesizes the literature on multimodal IONM in brachial plexus surgery to address these gaps and appraise the methodological quality of the underlying studies. Methods A PRISMA‐aligned systematic review was conducted using PubMed, Scopus, and the Cochrane Library. From 2909 records, 2120 unique studies were screened; 133 underwent full‐text review, and 44 met inclusion criteria. Methodological quality was evaluated using the Methodological Index for Non‐Randomized Studies (MINORS), scored out of 16. Data were synthesized qualitatively by modality and lesion type in adult and pediatric cohorts. Results The 44 included studies encompassed traumatic, iatrogenic, and obstetric injuries with substantial heterogeneity in IONM protocols and reporting. Nerve action potential (NAP) recording was the primary modality for lesions in continuity, with conducting lesions preserved and managed by neurolysis. However, the corollary rule that a non‐conducting lesion should be resected and grafted was not applied uniformly and is not supported by consistent data: in one series, six of six lesions with complete functional loss and no recordable NAP but no caliber change recovered usefully after internal neurolysis rather than grafting. Adjunct modalities (EMG, MEP, SSEP, CMAP) rarely overrode NAP‐based decisions, although SSEPs and MEPs served the distinct role of separating preganglionic from postganglionic root injury. Of the 44 included studies, 11 assessed intraoperative NAPs, none of which reported explicit quantitative criteria for defining a positive NAP. Pediatric evidence was limited. Overall methodological quality was modest, with a median MINORS score of 9 of 16 (range 6–13); unbiased endpoint assessment was adequate in only 8 of 44 studies, and none reported a prospective sample‐size calculation. Conclusions Multimodal IONM is standard in brachial plexus surgery, with NAP recordings guiding decisions for lesions in continuity. The contribution of this review is to show that the literature used to justify NAP‐guided management is non‐comparative, internally inconsistent for the non‐conducting lesion, and rarely reports either a quantitative signal threshold or the grade of neurolysis performed. Prospective multicenter studies are needed to define signal thresholds, generate contemporary outcome data for non‐conducting lesions managed by preservation, and report the specific procedure meant by “neurolysis.” These needs are most acute in pediatric populations, where validated thresholds are entirely lacking.
No takes yet. Share an insight, caveat, or question.
Brandfield-Harvey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: